Skip to Main Content

About the Institute for Translational Virology & Innovation

USF Research Park

Groundbreaking research making an impact

The USF Health Institute for Translational Virology and Innovation (ITVI) is dedicated to tackling the world’s most urgent viral and microbial threats. As a Center of Excellence for the Global Virus Network (GVN), ITVI unites world-renowned scientists and clinicians to translate groundbreaking research into real-world impact for patients and communities.

Founded by legendary virologist Dr. Robert C. Gallo, ITVI is driving discovery across current programs in viral oncology, HIV and HTLV-1, microbial drivers of cancer, and functional HIV cure research. Future initiatives are expanding into human papillomavirus (HPV), Epstein-Barr virus (EBV), respiratory pathogens, arboviruses, and pandemic preparedness through genomic surveillance and bioinformatics.

With cutting-edge facilities, global collaborations, and direct integration into Tampa General Hospital’s Cancer Institute, ITVI brings scientific innovation from the laboratory bench to the patient’s bedside. Anchored at USF Health in Tampa, the Institute is also training the next generation of virology leaders while fostering biotech partnerships that fuel innovation and strengthen pandemic preparedness.

 

 

 

 

USF Health Making Life Better

 

In The News